Acne Channel
Topics & Medications
Quicklinks
Related Channels

Differin Patent Expiration

Differin® (adapalene) is a prescription skin medication approved for the treatment of acne. It is currently under the protection of a patent that prevents any generic versions of the medication from being manufactured in the United States.
 
The first patent expiration date for Differin is May 2010. This is the earliest predictable date that a generic version could become available. However, some Differin products have additional patents or exclusivity rights that extend much later.
 
There are also other circumstances that could come up to extend or shorten the exclusivity period of Differin. This could include such things as lawsuits or other patents for specific Differin uses.
 
(For more details on when the patents for this medication expire, click Generic Differin. This full-length article also explains the difference between a "generic name" and a "generic version" of a medication.)
 
Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2017 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.